Suppr超能文献

内源性血浆纤维蛋白溶解:尿激酶相关活性在不依赖因子 XII 的纤溶酶原激活物途径中的作用。

Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.

作者信息

Kluft C, Wijngaards G, Jie A F

出版信息

J Lab Clin Med. 1984 Mar;103(3):408-19.

PMID:6199446
Abstract

A portion of human blood fibrinolytic activity can be quenched by antibodies to urokinase. We attempted to identify this portion and its position in the three pathways (extrinsic, intrinsic factor XII dependent, and intrinsic factor XII independent) of plasminogen activator activity that have been defined in the DEFs of plasma. Activity quenching in various plasmas (including plasma adsorbed by agarose-bound AUK) demonstrated the involvement of a discrete activator activity of 40 to 50 BAU/ml with little variation among individuals (43 +/- 6 (SD) BAU/ml, n = 13). The quenching did not involve, quantitatively or qualitatively, the extrinsic (tissue-type) plasminogen activator activity varying between 1 and 146 BAU/ml in baseline plasma and in plasma obtained after stimulation by venous occlusion, exercise, or DDAVP administration. In confirmation, extrinsic activator activity was recovered in plasma adsorbed by agarose-bound AUK. The quenching also did not involve the factor XII-dependent activities; it was quantitatively normal in plasma with Hageman (n = 3) and Fletcher (n = 2) traits, and AUK did not interfere with the generation of factor XII-dependent fibrinolytic activity by addition of purified activated factor XII in plasma with Hageman trait. There was no effect of AUK on kallikrein generation, kallikrein activities, or the APPT, nor were these aspects altered in depleted plasma. In conclusion, the quenching involved the factor XII-independent system of intrinsic fibrinolysis. Addition of purified urinary urokinase did not result in restoration of missing activity in plasma adsorbed by AUK-agarose. The quenching, therefore, probably involved an apparent urokinase-related activator component in plasma.

摘要

人血纤溶活性的一部分可被抗尿激酶抗体淬灭。我们试图确定这一部分及其在血浆中已定义的纤溶酶原激活物活性的三条途径(外源性、依赖因子XII的内源性和不依赖因子XII的内源性)中的位置。在各种血浆(包括琼脂糖结合的抗尿激酶吸附的血浆)中的活性淬灭表明,存在一种40至50 BAU/ml的离散激活物活性,个体间差异很小(43±6(标准差)BAU/ml,n = 13)。淬灭在数量或质量上均不涉及外源性(组织型)纤溶酶原激活物活性,其在基线血浆以及静脉阻塞、运动或给予去氨加压素刺激后获得的血浆中,活性在1至146 BAU/ml之间变化。经证实,外源性激活物活性在琼脂糖结合的抗尿激酶吸附的血浆中得以恢复。淬灭也不涉及依赖因子XII的活性;在具有哈格曼(n = 3)和弗莱彻(n = 2)特征的血浆中,其数量正常,并且在具有哈格曼特征的血浆中添加纯化的活化因子XII时,抗尿激酶不干扰依赖因子XII的纤溶活性的产生。抗尿激酶对激肽释放酶的产生、激肽释放酶活性或活化部分凝血活酶时间均无影响,在耗尽的血浆中这些方面也未改变。总之,淬灭涉及内源性纤溶的不依赖因子XII的系统。添加纯化的尿激酶并不能恢复抗尿激酶 - 琼脂糖吸附的血浆中缺失的活性。因此,淬灭可能涉及血浆中一种明显的尿激酶相关激活物成分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验